leukemia
Astellas Pharma Releases Phase II Data For Leukemia Drug
Approximately 50 percent of FLT3-ITD positive AML patients achieved complete remission with Astellas Pharma's new investigational drug, according to Phase II data results.
Borneo Tree Is Source Of Potential Anticancer Agent, Silvestrol
Scientists are trying to commercialize a natural compound derived from the Aglaia tree for its anti-cancer properties.
Del Mar Pharma Announces Strategic Collaboration In China
Del Mar Pharma announced on Monday a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the development of VAL-083, known in China as DAG for Injection.
Philippines: Cheaper Pediatric Cancer Drugs Raise Child Survival Rates
An NGO-government partnership in the Philippines has improved access to treatment for pediatric cancer, a leading cause of death in children aged 1-14, according to the Department of Health.
EntreMed Inc. Initiates Plans For China Office
EntreMed, Inc., has initiated plans to establish an office in China to facilitate the company’s drug development and clinical trials in that country.
Two Chinese Scientists Win The Szent-Györgyi Prize for Contributions To Leukemia Research
Two Chinese scientists have been awarded the 7th Annual Szent-Györgyi Prize by the National Foundation for Cancer Research for their contributions to leukemia research.
Study: Smoking Fathers Linked To Childhood Leukemia Risk
New research by Australian scientists suggests that children whose fathers smoked around the time of conception may have a 35 percent higher risk of developing childhood leukemia.
Australian Project To Highlight 15 Types Of “Forgotten Cancers”
The Forgotten Cancers Project launched yesterday by the Cancer Council Victoria hopes to understand the causes of less common and under-researched cancers.
ABT-199 BH-3 Mimetic Enters Phase Ia Trial For Chronic Lymphocytic Leukemia
A molecule discovered 20 years ago at the Walter and Eliza Hall Institute in Australia is now entering clinical trials to treat chronic lymphocytic leukemia.
